GA SB370

Adds Fluorophenylpiperazine (FPP) to Georgia's Schedule I controlled substances list under Code Section 16-13-25

Replaces six specifically named synthetic cannabinoids (e.g., JWH-018, HU-210, CP 47,497) with broader chemical categories covering entire classes of synthetic cannabinoid compounds, including naphthoylindoles, benzoylindoles, cyclohexylphenols, and synthetic cathinones derived from 2-aminopropan-1-one

Exempts synthetic cannabinoid-related compounds when used in commercial industrial manufacturing not intended for human consumption, prescribed under medical supervision, or used in research at recognized institutions

Adds Ezogabine to the Schedule V controlled substances list and adds approximately 30 new prescription drugs—including rivaroxaban, ipilimumab, crizotinib, and vilazodone—to Georgia's "dangerous drug" definition

Takes effect upon approval by the Governor or upon becoming law without such approval